METHODS
The study was conducted in a mixed residential-industrial urban area of the Maresme region at the Mediterranean coast in Barcelona, Spain.
Patients under 18 years of age were excluded from the study as were patients with aspiration pneumonia or active pulmonary tuberculosis, and patients coming from nursing homes or having being discharged from hospital < 7 days before the onset of symptoms. Other exclusion criteria were congenital hypogammaglobulinemia, active malignancy or hematologic disease, infection by the human immunodeficiency virus For each patient, demographic (age and sex) and clinical data were recorded, including alcoholism (consumption of ≤ 80 g ethanol/day for at least in the past 12 months); current smoking (consumption of > 10 cigarettes/day for at least in the past 12 months); chronic respiratory disease, such as chronic bronchitis (defined by clinical or spirometric criteria), asthma, bronchiectasis, and sequelae of tuberculosis or other interstitial lung disease; chronic cardiovascular disease defined as a clinical or echocardiographic diagnosis of heart failure, ischemic heart disease (clinical features or diagnostic studies), valvular heart disease, and other causes such as rhythm disturbances or malformations; neurologic disease included cerebrovascular or neurodegenerative disorders; diabetes mellitus was defined as glucose intolerance or treatment with oral antidiabetic drugs or insulin; chronic liver disease included toxic or viral causes and compensated liver cirrhosis; chronic renal failure was defined in the presence of chronic serum creatinine levels > 2 mg/dL or blood urea nitrogen > 40 mg/dL; and no evidence of active malignancy for the preceding year, except for basal cell and squamous cell carcinoma of the skin. The use of oral corticosteroids at doses < 20 mg/day or prednisone or equivalent doses was also registered.
CONTROL GROUP:
For each case, a control healthy subject was recruited. Control subjects were randomly selected from the municipal census and were matched by age (±5 years), sex, and place of residence. All controls gave written informed consent to IgG in community-acquired pneumonia draw a blood sample for the immunologic study and to be interviewed to collect data on the study variables.
